These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16167414)

  • 1. Inpatient management of severe psoriasis.
    Nelson AA; Pearce DJ; Fleischer AB; Balkrishnan R; Feldman SR
    J Drugs Dermatol; 2005; 4(5):564-70. PubMed ID: 16167414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab for inpatient psoriasis management--is there a role?
    Nelson AA; Pearce DJ; Fleischer AB; Balkrishnan R; Feldman SR
    J Dermatolog Treat; 2005; 16(5-6):314-8. PubMed ID: 16428151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.
    Naldi L; Griffiths CE
    Br J Dermatol; 2005 Apr; 152(4):597-615. PubMed ID: 15840088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical effects of cost reduction measures in managed care systems for treatment of severe psoriasis.
    Yentzer BA; Yelverton CB; Simpson GL; Simpson JF; Hwang W; Balkrishnan R; Feldman SR
    Dermatol Online J; 2009 Apr; 15(4):1. PubMed ID: 19450394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological therapies in the systemic management of psoriasis: International Consensus Conference.
    Sterry W; Barker J; Boehncke WH; Bos JD; Chimenti S; Christophers E; De La Brassinne M; Ferrandiz C; Griffiths C; Katsambas A; Kragballe K; Lynde C; Menter A; Ortonne JP; Papp K; Prinz J; Rzany B; Ronnevig J; Saurat JH; Stahle M; Stengel FM; Van De Kerkhof P; Voorhees J
    Br J Dermatol; 2004 Aug; 151 Suppl 69():3-17. PubMed ID: 15265063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
    Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative non randomized study of narrow-band (NB) (312 +/- 2 nm) UVB phototherapy versus sequential therapy with oral administration of low-dose Cyclosporin A and NB-UVB phototherapy in patients with severe psoriasis vulgaris.
    Calzavara-Pinton P; Leone G; Venturini M; Sala R; Colombo D; La Parola IL; Sitzia N; Ferraro C; Picardo M
    Eur J Dermatol; 2005; 15(6):470-3. PubMed ID: 16280301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
    Smith CH; Jackson K; Bashir SJ; Perez A; Chew AL; Powell AM; Wain M; Barker JN
    Br J Dermatol; 2006 Jul; 155(1):160-9. PubMed ID: 16792769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology].
    Puig L; Bordas X; Carrascosa JM; Daudén E; Ferrándiz C; Hernanz JM; López-Estebaranz JL; Moreno JC; Sánchez-Carazo JL; Vanaclocha F; Vázquez-Veiga H;
    Actas Dermosifiliogr; 2009 May; 100(4):277-86. PubMed ID: 19463230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phototherapy and photochemotherapy.
    Schneider LA; Hinrichs R; Scharffetter-Kochanek K
    Clin Dermatol; 2008; 26(5):464-76. PubMed ID: 18755365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home ultraviolet B phototherapy: a cost-effective option for severe psoriasis.
    Yelverton CB; Kulkarni AS; Balkrishnan R; Feldman SR
    Manag Care Interface; 2006 Jan; 19(1):33-6, 39. PubMed ID: 16453993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study.
    Schöffski O; Augustin M; Prinz J; Rauner K; Schubert E; Sohn S; Reich K
    J Dtsch Dermatol Ges; 2007 Mar; 5(3):209-18. PubMed ID: 17338796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood psoriasis.
    Benoit S; Hamm H
    Clin Dermatol; 2007; 25(6):555-62. PubMed ID: 18021892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Care of patients with psoriasis: an audit of U.K. services in secondary care.
    Eedy DJ; Griffiths CE; Chalmers RJ; Ormerod AD; Smith CH; Barker JN; Potter J; Ingham J; Lowe D; Burge S
    Br J Dermatol; 2009 Mar; 160(3):557-64. PubMed ID: 19120330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
    Sukarovska BG; Lipozencić J; Vrzogić P
    Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of inpatient treatment on quality of life and clinical disease severity in atopic dermatitis and psoriasis vulgaris - a prospective study.
    Schmitt J; Heese E; Wozel G; Meurer M
    Dermatology; 2007; 214(1):68-76. PubMed ID: 17191051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of treatment on quality of life in psoriasis patients.
    Prins M; Krabbe PF; Swinkels QO; de Boo T; van de Kerkhof PC; van der Valk PG
    Acta Derm Venereol; 2005; 85(4):304-10. PubMed ID: 16191850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do utilization management controls for phototherapy increase the prescription of biologics?
    Simpson GL; Yelverton CB; Rittenberg S; Feldman SR
    J Dermatolog Treat; 2006; 17(6):359-61. PubMed ID: 17853310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness and cost of treatment failures associated with systemic psoriasis therapies.
    Pearce DJ; Nelson AA; Fleischer AB; Balkrishnan R; Feldman SR
    J Dermatolog Treat; 2006; 17(1):29-37. PubMed ID: 16467021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.